Hong Sung Ok, Chen Yu-Feng, Jung Junho, Kwon Yong-Dae, Liu Stanley Yung Chuan
Department of Dentistry (Oral and Maxillofacial Surgery), Catholic Kwandong University School of Medicine, International St. Mary's Hospital, Incheon, South Korea.
Stanford University School of Medicine, Stanford, CA USA.
Maxillofac Plast Reconstr Surg. 2017 Sep 25;39(1):27. doi: 10.1186/s40902-017-0126-0. eCollection 2017 Dec.
The prevalence of obstructive sleep apnea (OSA) is estimated to be 1-5% of the adult population world-wide, and in Korea, it is reported at 4.5% of men and 3.2% of women (Age 40 to 69 years old). Active treatment of OSA is associated with decrease in insulin resistance, cardiovascular disease, psychosocial problems, and mortality. Surgical treatment of OSA has evolved in the era of neuromodulation with the advent of hypoglossal nerve stimulation (HGNS). We share this review of HGNS with our maxillofacial surgical colleagues to expand the scope of surgical care for OSA.
据估计，阻塞性睡眠呼吸暂停（OSA）在全球成年人口中的患病率为1%-5%，在韩国，据报道40至69岁男性的患病率为4.5%，女性为3.2%。积极治疗OSA与胰岛素抵抗、心血管疾病、心理社会问题及死亡率的降低相关。随着舌下神经刺激（HGNS）的出现，OSA的外科治疗在神经调节时代得到了发展。我们与颌面外科同事分享这篇关于HGNS的综述，以扩大OSA外科治疗的范围。
